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1001-27 Mete l lo th ione in  El ic i ts  Second Window of Myocardial 
Protection in Rabbit Hearts Through Mitogen-Activated 
Protein Kinase Mechanism 
Kui Chen. Junhau Zhang, Dayuan Li, Jawahar L Mehta, University of Arkansas for 
Medical Sciences, Little Rock, Arkansas, Central Arkansas Veterans Healthcare System, 
Little Rock, Arkansas. 
Background: Ischemic preconditioning (IPC) of rnyocardium displays a bimodal time 
course. Eady cardioprotaction wanes rapidly and is succeeded by a delayed phase. This 
"second window" of protection (SWOP) lasts up to 72 hours. Metallothionein, a stress- 
induced protein, is an important endogenous mediator exerting acute protective effects in 
the ischemic myocardium. We examined whether endogenous metallothionein could evoke 
SWOP (delayed myocardial protection). 
Methods and Results: Rabbits (n=18) were subjected to IPC with 4 cycles of 5-rnin regional 
ischemia each followed by 10-rain reperfusion. Twenty-four hours later, animals were sub- 
jected to sustained 45 min. ischemia followed by 60 rain repertusion (I/R). Parallel groups 
were sham control (n=10), or I (45min)/R (60 min)(n=10). Activity of mltogen-activatad pro- 
tein kinase (MAPK) in IPC rnyocardium was increased 10 to 12 times immediately after IPC 
(P<0.0f vs. sham control), and returned to control 24 hours later. In these expedments, 
myocardial metallothionein gene expression (Northern and Western blots) was increased 3 
to 7 times at 24 hours after IPC compared with that immediately after IPC as well as the 
sham control group (both P<0.01). Pretreatment of rabbits with PD098059 inhibited MAPK 
activation as well as metallothionein gene expression in response to IPC (P<0.01). Myocar- 
dial infarct size was assessed by "I-I'C staining and expressed as percent of Ask zone, Car- 
diac function was measured by monitoring ±dp/dt. IPC reduced infarct size (34 ±7% to 23 
±3%, a 48% reduction, n = 9, P<0.01). IPC also improved dp/dt (21938±1663mmHg to 
33609~3178mmHg, a 53% reduction, n=9, P<0.01). IPC also reduced lipid peroxidation 
and LDH release compared with that in non-IPC (both P<0.01). Importantly, we found that 
the myocardial metallothionain content was positively correlated to the reduction in infarct 
size and improvement in cardiac function. 
Conclusions: The upregulation of metallothionein gene expression induced by IPC plays 
an important role in the delayed protection of ischemic myocardium, The expression of 
metallothionein is mediated by the activation of MAPK in response to IPC. 
1001-28 Matr ix  Meta l loprote inase  Inh ib i t ion  Attenuates 
Postinfarctlon Left Ventriculer Remodeling 
Sunil Mankad, J. Thomas Paterson, Leah TsekelI-Taylor, James A. Magovern, Robed W. 
W. Biederman, Walter J. Rogers, Jane Ripple, June Yamrozik, Nathaniel Raichak, 
Allegheny Genera/Hospital, Pittsburgh, Pennsylvania, SL Francis, Roslyn, New York. 
Myocardial matrix matalloprotainase activity is increased following expedmectal MI and may 
play a role in post-infarction LV remodeling. However, effects of matrix metalloproteinase 
inhibition (MMPi) on post-infarction LV remodeling and systolic function remain incompletely 
understood. Accordingly, MMPi was studied in a well-characterized ovine post-infarction 
model. One day after anteroapical MI by coronary ligation, 14 sheep were randomized to 
either no therapy (Control, n--8) or non-selective MMPi (PD166793 - Pfizer, Inc.; n=6), Mag- 
netic resonance imaging (GE/CVi) was performed at baseline and at 8-weeks post-MI to 
quantify changes in LV end-systolic volume index (ESVi), end-diastolic volume index (EDVi), 
ejection fraction (EF), and mass index (LVMi). Results: Infarct size as a % of LV mass was 
similar for MMPi vs Control: 17±1 vs 17±2 %. Left atdal pressure at 8-weeks post-MI was 
not different: 9¢2 vs 8±2 mmHg. Baseline LV EDVi, ESVi, EF, and LVMi were similar 
between groups. There was significant limitation of LV remodeling and greater preservation 
of EF at 8-weeks post-MI with MMPi compared to Control (see Table). At 8-wseks post-MI, 
EDVi and ESVi were significantly lower with MMPi compared to Control: 1.8¢0.1 * vs 2.4i-0.2 
ml/kg and 1.1±0.1" vs 1.6±0.2 ml/kg (*p<0.04). Conclusions: Non-selective MMPi attenu- 
ated post-infarction LV remodeling in this large animal model. Unlike smaller animal models, 
however, MMPi also better preserved global LV systolic function following MI. 
Change In LV Remodeling Parameters (*p<0.02 vs Control) 
EDVI (ml/kg) ESVI (ml/kg) EF (%) LVMI (g/kg) 
MMPI +0.4±0.1" +0.4±0.1" -14±2" +0.1±0.1 
Control +0.8±0.1 +0.9±0.1 -21±2 +0.2±0.1 
1001-29 Phosphat idy l inoe i to l  3 -K inase /Akt  Pathway Contributes 
to Ischemic Preconditioning in Iso lated Rabbi t  Heart  
Zhe Jiao. Olena M. Gorodnya, James M, Downey, Tai-Hwang M. Fan, Emory Univ and 
Atlanta VA Med Ctr, Decatur, Georgia, Univ of South Alabama, Mobile, Alabama. 
Background: Several growth factors and cytokines have been shown to trigger cell sur- 
vival signaling via activation of the phosphatidylinositol 3-kinase (PI3 kinase)/Akt path- 
way. The present study examined whether activation of PI3 kinase/Akt plays a role in the 
cardioprotective mechanism of ischemic preconditioning (PC). Methods: Adult rabbit 
hearts perfused in the Langendodf fashion were subjected to 30 rain of global ischemia 
followed by 2 h of reparfusion. PC was achieved by pre-exposing the heart to 5 rain of 
global ischemia followed by 10 min of reperfusion before the standard ischemia-repedu- 
sion treatment. To evaluate the role of phospho-Akt (the active form of Akt) in the cardio- 
protection of PC, the PI3-kinase inhibitor wortmannin was used to deplete phospho-Akt. 
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Wortmannin (100 nM) infusion was started 5 min before the preconditioning ischemia 
and continued until the index ischemia. Infarct size was determined by computer mor- 
phometry of "l-rC stained sections. Phospho-Akt (Ser473) levels were determined by 
Western blot analysis in a separate series of hearts, in which serial biopsies were taken 
at basetine and at 5, 10, 20, 30 rain of ischemia. Raaulte: The PC hearts exhibited 
smaller infarct size (24+ 5%, n=6) than in the control group (50-+ 5%, n=6). In the 
PC+Wortmannin group, the infarct size was 53+ 10% (n=6). In the control heads, 
ischemia caused a progressive loss of phospho-Akt, such that at 30 rain of ischemia the 
phospho-Akt level was only 14_+ 2% of baseline. PC significantly attenuated the 
ischemia-induosd loss of phospho-Akt, such that at 30 min of ischemia the phospho-Akt 
level was maintained at 39_+ 8% of baseline (p<0.05 vs control group). PC+Wortmannin 
group showed complete depletion of phospho-Akt. Conclualon: Myocardial ischemia is 
associated with a marked depletion of phospbo-Akt. PC preserves phospho-Akt level in 
the ischemic myocardium and protects the heart from ischemia/reperfusion-induced cell 
death. The cardioprotective ffect of PC could be completely abolished by depletion of 
phospho-Akt via inhibition of PI3-kinase. Thus, activation of the PI3-kinase/Akt pathway 
appears to be an important mechanism mediating PC-induced cardioprotaction. 
1001-30 Endocardlal Cryotherapy Induces Marked 
Arteriogenesis in Normal Porcine Myocardium 
Richard Gallo, Patdck Chauvet, Mike Urick, Allen Burke, Renu Virrnani, Montreal Heart 
Institute, Montreal, Quebec, Canada. 
Background: Percutanecus Myocardial Revascularizarion (PMR) using heat-based cathe- 
ters (rediofrequency, laser) has been studied extensively in recent clinical trials with contro- 
versial results. However, the myocardial response may be substantially different with cold 
therapy. Therefore, we studied the neovascular response of myocardial tissue following 
exposure to cryo-energy in a non-ischamic porcine model. 
Methods: Cryo-energy was applied to the endocardium using a 7Fr Freezer TM focal cryo- 
catheter (CryoCath Technologies) in the left ventdcle of 25 normal swine. Up to 8 discreet 
treatments of varying temperature (-30 to -75°C) and time (30 to 120 sac) were performed. 
Hearts were harvested at 4 weeks, the coronary adedes were perfusion fixed and injected 
with a banum gelatin. 
Results: Histological analysis revealed clearly demarcated lesions extending into the myo- 
cardial wall. Capillary, arteriole and muscular artery vessel densities were assessed in nor- 
mal myocardium, within the cryo-lesion and at 1 mm margin around the cryo-lesion using 
lectin, actin and etastin stains. While capillary density (rYmm2) decreased in the 1ram rim 
(1492 ± 679, P<0,001 ) and in the lesion (218 ± 183, P<0.001) as compared to control myo- 
cardium (3154 ± 792), arteriole density increased significantly in the 1turn Am (7.02 ± 4.87, 
P<0.O01) and in the lesion (7.62 ± 4.81, P<0.001) as compared to control (4,62 ± 1.36). 
Muscular artery density also increased in the 1 mm region (0.34 ± 0,37, P<0.001) and in the 
lesion (0.35 ± 0,30, P<0.001) vs. control (0.05 ± 0.03), Artetiolar density correlated with 
lesion volume indicating possible release of growth factors or cytokinas during lesion for- 
marion and subsequent healing response. Badum gelatin infusion confirmed communica- 
tion of arterioles and muscular arteries with the apicardial coronary arteAes. 
Conclusion: Endocardial cryoapplications in the range of -30°C to -75°C can induce 
marked arteriogenesis within the myocardium of non-ischemic pigs. This energy source 
may represent a promising alternative for patients suffering from myocardial ischemia with 
limited therapeutic options. 
1001-47 Adenosine Administered From the Beginning of  
Reperfusion Protected Myocardial Stunning by 
Activation of A1 Receptors and K+ATP Channels 
Martin Donato, Veronica D'Annunzio, Calina Morales, Melina Saban, Omar Scapin, 
Ricardo J. Gelpi, Fundacion Grupo de Estudios Multicentricos en Argentina (GEMA), 
Universidad de Buenos Aires, Buenos Aires, Argentina. 
Background: There is expedmental evidence that adenosine (ADO), added from the begin- 
ning of reperfusien attenuates systolic and diastolic alterations in myocardial stunning. The 
aim was to determine the participation of A1 receptors and ATP K+ channels acting as 
mediators of the above effects. Methods: Isolated rabbit heads were used and four groups 
were formed. Group 1 (G1, n=14) was subjected to 15 rain of global ischernia followed by 
30 min of repeffusion. In Group 2 (G2, n=12) the protocol of G1 was repeated but adding 
ADO (0.3 mg/kg/min) to the perfosate from the beginning of reperfusion. In Group 3 (G3, 
n=12) the protocol of G2 was repeated, but DPCPX (200 nM), a selective blocking agent of 
A1 receptors, was administered in presence of ADO. In Group 4 (G4, n=9) the protocol of 
G2 was repeated, but glibenclamide (0.3 pM), a blocking agent of ATP K+ channels, was 
administered in presence of ADO. Left ventricular developed pressure (LVDP, mmHg) and 
left ventdcular end diastolic pressure (LVEDP, mmHg) (diastolic stiffness) were calculated, 
and the infarct size measured. Results: Infarct size was not different between G1 and G2 
(2.75±0.8 and 4.35±1.6; NS), but it was bigger in G3 and G4 (10.7±1.3 and 12.7±2.2; 
p<O.05) compared to GI. X±SEM *:p<0.05 vs GI. Conclusions: ADO administered from 
the beginning of reperfusion attenuated the alteration of contractile state and diastolic stiff- 
ness by the activation of A1 receptors and K+ATP channels. The ADO protection was inde- 
pendent of the modification in the infarct size. 
